Navigation Links
ExonHit Therapeutics: Allergan and ExonHit's First Collaboration Compound to Begin Human Clinical Trials
Date:8/27/2007

PARIS, August 28 /PRNewswire-FirstCall/ -- ExonHit Therapeutics, a drug and diagnostic discovery company, today announced that its drug discovery collaboration with Allergan Inc. (NYSE: AGN), a global speciality pharmaceutical and medical device company, has reached a success milestone. As a result of the efforts of the Allergan and ExonHit research team, human clinical testing will be initiated on the first collaboration New Chemical Entity (NCE). This NCE (designated EHT/AGN001) has a novel mechanism of action and will enter a phase I study later this year.

The objectives of Allergan and ExonHit's strategic collaboration are to identify, develop and commercialise drugs targeted at the treatment of neurodegenerative diseases, pain and ophthalmology. The collaboration was initiated in 2003 and has been extended twice as a consequence of its good productivity.

"We are happy to see that this collaboration has lead to a clinical candidate in such a short period of time. This success is a result of the dedicated efforts and focus by the research teams from both companies," said Dr. Scott Whitcup, Executive Vice President, Research & Development of Allergan Inc.

"By industry standards, this collaboration's productivity is exceptional, delivering a clinical product in less than four years together with two other innovative pre-clinical projects," stated Bruno Tocque President of the Management Board of ExonHit. He added "I would like to express my gratitude to our scientists who have developed a drug discovery engine enabling this achievement".

Under the terms of the agreement, Allergan will assume responsibility for the ongoing clinical development and commercialisation of EHT/AGN001. Contingent upon
'/>"/>

SOURCE ExonHit Therapeutics SA
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. The Genesis of Gendicine: The Story Behind the First Gene Therapy
2. Midwest life science stocks sizzle in a tepid first quarter
3. Morgridge Institute for Research seeks first CEO
4. Sonic Foundry reports first cash-positive quarter
5. Angel investors commit $12.7B in first half of `06
6. Aurora team implants Wisconsins first total artificial heart
7. First half of 2006 roundup: Big Pharma trumps biotech
8. GE announces first installation of Discovery VCT
9. GE Healthcare enjoys robust growth in first quarter
10. Madison asks for wireless bids; airport, downtown would be first
11. Tech Digest: Inacom, PKWare at Infosecurity, Firstlogic, Teklynx

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)...L, Nov. 19 /PRNewswire/ - Aegera Therapeutics Inc....n a randomized Phase 2B study of AEG35156, a targe... for multiple oncology indications. ,, The stud...y of the X-Linked Inhibitor of Apoptosis (XIAP) An...se Cytarabine and Idarubicin in AML Following Fail...
(Date:11/18/2009)...alif., Nov. 18 Marrone Bio Innovat... and commercialization of effective and environmen...ced that it has been named an IC20 company by the ...argest national angel investing group. ,, Compa...g to rewarding results for all stakeholders, inclu...
(Date:11/18/2009)...ND, Calif., Nov. 18 Sang...oday that data from the University of Pennsylvania...ngamo,s zinc finger nuclease (ZFN) based product, ...aturely disclosed on the internet. ,, Data were...f Pennsylvania School of Medicine from a single su...
(Date:11/18/2009)...UGA, ON, Nov. 18 /PRNewswire-FirstCall/ - YM BioSc...iences product development company that identifies...cer-related products at various stages of developm...g nimotuzumab were presented today in a poster at ...er Therapeutics conference in Boston, Massachusett...
Breaking Biology Technology:Aegera Therapeutics Initiates a Randomized Phase 2B Study with AEG35156 for the Treatment of Acute Myeloid Leukemia (AML) 2Marrone Bio Innovations Named an IC20 Company 2Sangamo BioSciences Provides Update on Phase 1 Safety Trial of SB-728-T for HIV/AIDS 2YM BIOSCIENCES ANNOUNCES NIMOTUZUMAB RESULTS IN ADVANCED TRIPLE-NEGATIVE BREAST CANCER MODEL PRESENTED AT AACR-NCI-EORTC MEETING 2YM BIOSCIENCES ANNOUNCES NIMOTUZUMAB RESULTS IN ADVANCED TRIPLE-NEGATIVE BREAST CANCER MODEL PRESENTED AT AACR-NCI-EORTC MEETING 3
...ola Hughes, 1 Antony Harvey, 2 Witold Winnik, 3 ...aurizio Splendore, 2 and Gary Paul 3 , ,...,Canada; , 2Thermo Finnigan,San Jose,CA,US... , , , , , , Systemic ...as acquired on a Thermo Finnigan TSQ Quantum , ...
...ing the optimal reagent for your cells , , ...s , Kit Contents , Storage and ...Technical Assistance , Introduction ,...rFect Transfection Reagent , , ...Reagent , , , General Gui...
...hredder spin columns are designed for simple and r...sates. , , , , , , , ...Mini spin columns, , , ...l or human cell or tissue lysates, , ...ates, , , Sample si...
Other Biology Technology:Quantitation of Cabergoline at Extremely Low Plasma Concentrations with , a Triple Quadrupole Mass Spectrometer 2Quantitation of Cabergoline at Extremely Low Plasma Concentrations with , a Triple Quadrupole Mass Spectrometer 3Quantitation of Cabergoline at Extremely Low Plasma Concentrations with , a Triple Quadrupole Mass Spectrometer 4Quantitation of Cabergoline at Extremely Low Plasma Concentrations with , a Triple Quadrupole Mass Spectrometer 5Quantitation of Cabergoline at Extremely Low Plasma Concentrations with , a Triple Quadrupole Mass Spectrometer 6Quantitation of Cabergoline at Extremely Low Plasma Concentrations with , a Triple Quadrupole Mass Spectrometer 7Quantitation of Cabergoline at Extremely Low Plasma Concentrations with , a Triple Quadrupole Mass Spectrometer 8Transfection Reagent Selector Kit Handbook 2Transfection Reagent Selector Kit Handbook 3Transfection Reagent Selector Kit Handbook 4Transfection Reagent Selector Kit Handbook 5Transfection Reagent Selector Kit Handbook 6Transfection Reagent Selector Kit Handbook 7Transfection Reagent Selector Kit Handbook 8Transfection Reagent Selector Kit Handbook 9Transfection Reagent Selector Kit Handbook 10Transfection Reagent Selector Kit Handbook 11Transfection Reagent Selector Kit Handbook 12Transfection Reagent Selector Kit Handbook 13Transfection Reagent Selector Kit Handbook 14Transfection Reagent Selector Kit Handbook 15Transfection Reagent Selector Kit Handbook 16Transfection Reagent Selector Kit Handbook 17Transfection Reagent Selector Kit Handbook 18Transfection Reagent Selector Kit Handbook 19Transfection Reagent Selector Kit Handbook 20Transfection Reagent Selector Kit Handbook 21Transfection Reagent Selector Kit Handbook 22Transfection Reagent Selector Kit Handbook 23Transfection Reagent Selector Kit Handbook 24Transfection Reagent Selector Kit Handbook 25Transfection Reagent Selector Kit Handbook 26Transfection Reagent Selector Kit Handbook 27Transfection Reagent Selector Kit Handbook 28Transfection Reagent Selector Kit Handbook 29
(Date:11/20/2009)...) Scientists from the Marine Biogeochemistry and ...rch Laboratory (NRL) organized and led a team of u...xpedition to initiate methane hydrate exploration ...ation of sediment contribution to Arctic climate c...olar Sea as a research platform, three cross-shelf...
(Date:11/20/2009)...cteria possess an ingenious mechanism for preventi...cell. This is the new finding of a team of biologi...ences research institute in Flanders, Belgium, con...ntists made this discovery by modifying the DNA of...eans of this model organism, they have uncovered t...
(Date:11/20/2009)... researchers report that a class of heart medicati...rmful, effect on the heart, depending on their mol...he journal Circulation Research , found that beta...eptors on the heart muscle offer the most benefit ...the beta-receptors can actually undermine the stru...
Breaking Biology News(10 mins):International expedition investigates climate change, alternative fuels in Arctic 2Biologists discover bacterial defense mechanism against aggressive oxygen 2Carvedilol shown to have unique characteristics among beta blockers 2Mediterranean diet associated with reduced risk of depression 10311 1Mediterranean diet associated with reduced risk of depression 10311 2Common herbicides and fibrates block nutrient sensing receptor found in gut and pancreas 10307 1Common herbicides and fibrates block nutrient sensing receptor found in gut and pancreas 10307 2Miscarriage Treatment Wont Harm Future Fertility 3A Study 59205 1Miscarriage Treatment Wont Harm Future Fertility 3A Study 59205 2
...g the strange properties of quantum mechanics to t...loser by a series of recent developments. The exci...uantum optics and discussed recently at a high lev...undation in collaboration with the Fonds zur Frder...(FWF) and the Leopold-Franzens-Universitt Innsbruc...
...erman . , For an organism to develop and functio... or communicate, with each other. Is it possible t...s it is: Cameron Alexander and George Pasparakis a... to facilitate a conversation between bacterial ce...l Angewandte Chemie they report that this first co...
...a are on the rise, but there is little evidence to...ational organizations that pirates and terrorists ...ng to a RAND Corporation study issued today. , Th... piracy is aimed at financial gain while the goal ...e increasing, piracy is growing much faster and re...
Other Biology News:Europe gets together to harness quantum physics 2Europe gets together to harness quantum physics 3Europe gets together to harness quantum physics 4Talking to cells 2RAND study finds increase in piracy and terrorism at sea 2RAND study finds increase in piracy and terrorism at sea 3
...kinase (JNK) is one of the several main MAP kinase...itive reporter for studying gene regulation and fu...n sensitivity in comparison to the standard chlora...uciferase catalyzes the oxidative carboxylation of...
CORNING CELLSTACK FILLINGD CAP, 33MM, BARBED FITTING, STERILE from Sigma-Aldrich
CORNING CELLSTACK VENTED CAP, 33MM, STERILE, 0.2UM MEMBRANE from Sigma-Aldrich
... were cultured in DMEM and harvested at the log ph...heir native forms, cells were fixed in acetone-met...adhesive coated slide, with each wells surface spe...nd to minimize background staining. Each well is ...
Biology Products: